Patent ID: 8372958

Claim:
A composition comprising an amount of an isolated monoclonal antibody effective to provide protection against staphylococcal infection in neonates and a pharmaceutically acceptable carrier, wherein the antibody specifically binds to poly-glycerol phosphate of Lipoteichoic acid (LTA) of Staphylococcus and is of the IgG isotype, wherein the antibody binds to and enhances opsonization of multiple serotypes of Staphylococcus epidermidis , coagulase negative staphylococci, Staphylococcus aureus and Streptococcus mutans by phagocytic cells with or without complement as compared to an appropriate control in an in vitro opsonization assay, wherein the antibody binds the same epitope to which MAB 96-110 antibody binds, and wherein the MAB 96-110 antibody is produced by the hybridoma deposited at ATCC Accession No HB-12368.